Form 8-K - Current report:
SEC Accession No. 0001213900-22-004356
Filing Date
2022-01-31
Accepted
2022-01-31 07:30:56
Documents
14
Period of Report
2022-01-31
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea154654-8k_bluejay.htm   iXBRL 8-K 25039
2 PRESS RELEASE DATED JANUARY 31, 2022 ea154654ex99-1_bluejay.htm EX-99.1 13319
3 GRAPHIC ex99-1_001.jpg GRAPHIC 3696
  Complete submission text file 0001213900-22-004356.txt   223221

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bjdx-20220131.xsd EX-101.SCH 3036
5 XBRL LABEL FILE bjdx-20220131_lab.xml EX-101.LAB 34476
6 XBRL PRESENTATION FILE bjdx-20220131_pre.xml EX-101.PRE 22597
8 EXTRACTED XBRL INSTANCE DOCUMENT ea154654-8k_bluejay_htm.xml XML 3721
Mailing Address 360 MASSACHUSETTS AVENUE, SUITE 203 ACTON MA 01720
Business Address 360 MASSACHUSETTS AVENUE, SUITE 203 ACTON MA 01720 (978) 631-0152
Bluejay Diagnostics, Inc. (Filer) CIK: 0001704287 (see all company filings)

EIN.: 473552922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41031 | Film No.: 22571306
SIC: 3841 Surgical & Medical Instruments & Apparatus